Tag: Prescription Drugs
Genotype-Guided Antiplatelet Therapy Feasible, Effective
Genotype-guided therapy improves outcomes among CYP2C19 intermediate, poor metabolizers
Outcomes-Based Pricing Doesn’t Cut Costs of PCSK9 Inhibitors
Incremental cost-effectiveness ratio for PCSK9 inhibitor improved marginally in three refund scenarios
Low-Dose Abiraterone Acetate Noninferior for Prostate Cancer
Low-dose AA with low-fat breakfast had greater effect on PSA; similar effect to standard dose
Educational Attainment Down With In Utero Exposure to AEDs
Exposure to sodium valproate, combo of antiepileptic drugs tied to worse attainment on national tests
Intravitreal Anti-VEGF Use Not Tied to Systemic Adverse Events
Risk not up in neovascular age-related macular degeneration, diabetic macular edema
Nivolumab Plus Ipilimumab Tops Sunitinib for Advanced Renal CA
Overall survival, objective response higher than sunitinib for untreated clear-cell advanced RCC
Siponimod Cuts Risk of Disability Progression in Multiple Sclerosis
Reduction in 3-month confirmed disability progression in secondary progressive multiple sclerosis
Dipeptidyl Peptidase-4 Inhibitors in T2DM Linked to IBD
Higher risk of inflammatory bowel disease with longer use of dipeptidyl peptidase-4 inhibitor
Unique Risks Associated With Texting Medical Orders
Institute of Safe Medication Practices indicates risks such as abbreviations, autocorrection
Adjuvant Long-Acting Muscarinic Antagonist Improves Asthma
Versus adjuvant placebo, LAMA or LABA plus inhaled corticosteroids lowers risk of asthma exacerbations
